[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343027-105":59,"doc-detail-343027-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-incidence-and-mortality-in-china-2022","Cancer incidence and mortality in China, 2022","","National Cancer Center (NCC) reports nationwide cancer incidence and mortality statistics in China and releases comparable burden data in GLOBOCAN 2022. Using high-quality cancer registry reports from 2018, including 106 registries with continuous monitoring from 2010–2018, researchers build an age-period-cohort model to estimate 2022 incidence and mortality. Temporal trends of age-standardized rates from 2000–2018 are analyzed using 22 continuous registries.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-incidence-and-mortality-in-china-2022/343027/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-incidence-and-mortality-in-china-2022/343027.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":56},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data sources were used to estimate China’s cancer incidence and mortality in 2022?","Question",{"text":112,"@type":113},"High-quality cancer registry data from 2018 were used, including 106 registries with continuous monitoring from 2010 to 2018 for an age-period-cohort model. Age-standardized temporal trends from 2000 to 2018 used data from 22 continuous cancer registries.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What were the estimated numbers of new cancer cases and deaths in China in 2022?",{"text":117,"@type":113},"The study estimates about 4,824,700 new cancer cases and 2,574,200 new cancer deaths in China in 2022.",{"name":119,"@type":110,"acceptedAnswer":120},"How did age-standardized incidence and mortality change over time (2000–2018)?",{"text":121,"@type":113},"Across 2000–2018, the age-standardized incidence rate (ASIR) increased by about 1.4% per year, while the age-standardized mortality rate (ASMR) decreased by about 1.3% per year. Declines were observed for esophagus, stomach, and liver, while ASIR increased significantly for thyroid, prostate, and cervix.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343027,1790090327,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":56,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of the National Cancer Center 4 (2024) 47–53  \nContents lists available at ScienceDirect  \nJournal of the National Cancer Center  \njournal [homepage:](homepage: www.elsevier.com/locate/jncc)[ www.elsevier.com/locate/jncc](homepage: www.elsevier.com/locate/jncc)  \n| Full Length Article\u003Cbr>Cancer incidence and mortality in China, 2022 ✩\u003Cbr>Bingfeng Han1,†, Rongshou Zheng1,†, Hongmei Zeng1, Shaoming Wang1, Kexin Sun 1, Ru Chen 1, Li Li 1, Wenqiang Wei 1,∗, Jie He 2,∗\u003Cbr>1 Oﬃce for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China\u003Cbr>2 Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China |  | |\n| --- | --- | --- |\n| a r t i c l e i n f o\u003Cbr>Keywords: Cancer registry Incidence Mortality Statistics China | a b s t r a c t\u003Cbr>Background: The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. The International Agency for Research on Cancer (IARC) calculates and publishes the cancer burden of countries around the world every two years. To ensure consistency between the actual surveillance data in China and the data published by IARC, NCC has received approval from the National Health Commission and IARC to simultaneously release the cancer burden data for China in GLOBOCAN 2022.\u003Cbr>Methods: There were a total of 700 registries reporting high-quality data on cancer incidence and mortality across China in 2018, of which 106 registries with continuous monitoring from 2010 to 2018 were used to establish an age-period-cohort model to simulate the trend of cancer incidence and mortality and to estimate the incidence and mortality in China in 2022. In addition, we analyzed the temporal trends of age-standardized cancer incidence and mortality from 2000 to 2018 using data from 22 continuous cancer registries.\u003Cbr>Results: It was estimated about 4,824,700 new cancer cases and 2,574,200 new cancer deaths occurred in China in 2022. Cancers of the lung, colon-rectum, thyroid, liver and stomach were the top ﬁve cancer types, accounting for 57.42% of new cancer cases. Cancers of the lung, liver, stomach, colon-rectum and esophagus were the ﬁve leading causes of cancer deaths, accounting for 67.50% of total cancer deaths. The crude rate and age-standardized incidence rate (ASIR) were 341.75 per 100,000 and 201.61 per 100,000, respectively. The crude mortality rate was 182.34 per 100,000 and the age-standardized mortality rate (ASMR) was 96.47 per 100,000. The ASIR of all cancers combined increased by approximately 1.4% per year during 2000–2018, while the ASMR decreased by approximately 1.3% per year. We observed decreasing trends in ASIR and ASMR for cancers of the esophagus, stomach, and liver, whereas the ASIR increased signiﬁcantly for cancers of the thyroid, prostate, and cervix.\u003Cbr>Conclusions: Cancer remains a major public health concern in China, with a cancer proﬁle that reﬂects the coexistence of developed and developing regions. Sustained implementation of prevention and control measures has resulted in signiﬁcant reductions in the incidence and mortality rates of certain historically high incidence cancers, such as esophageal, stomach and liver cancers. Adherence to the guidelines of the Healthy China Action Plan and the Cancer Prevention and Control Action Plan, along with continued eﬀorts in comprehensive risk factor control, cancer screening, early diagnosis and treatment, and standardization of diagnostic and therapeutic protocols, are key strategies to eﬀectively mitigate the increasing cancer burden by 2030. |  |\n\n1. Introduction  \nCancer has become a major public health problem in China, seriously aﬀecting the health of Chinese residents, the national economy and the soc","cbCaiklfULd7k4gt","https://ap.wps.com/l/cbCaiklfULd7k4gt","pdf",975617,"English","# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What data sources were used to estimate China’s cancer incidence and mortality in 2022?\",\"answer\":\"High-quality cancer registry data from 2018 were used, including 106 registries with continuous monitoring from 2010 to 2018 for an age-period-cohort model. Age-standardized temporal trends from 2000 to 2018 used data from 22 continuous cancer registries.\"},{\"question\":\"What were the estimated numbers of new cancer cases and deaths in China in 2022?\",\"answer\":\"The study estimates about 4,824,700 new cancer cases and 2,574,200 new cancer deaths in China in 2022.\"},{\"question\":\"How did age-standardized incidence and mortality change over time (2000–2018)?\",\"answer\":\"Across 2000–2018, the age-standardized incidence rate (ASIR) increased by about 1.4% per year, while the age-standardized mortality rate (ASMR) decreased by about 1.3% per year. Declines were observed for esophagus, stomach, and liver, while ASIR increased significantly for thyroid, prostate, and cervix.\"}]","Cancer incidence and mortality in China, 2022 | PDF",1790049474,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ac050aa84679014b2e54d2dbfb43299.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5953caf6f567b5566fdd18f347616612.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2549e001c4e1a44bc144a6031610bdc.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cf2d6b56ae1408f17bb28ca12a513fc.webp",980,1306]